Tiziana Life Sciences (TLSA): Book Value per Share
Tiziana Life Sciences (TLSA) relies on rigorous planning and external GMP contractors for the production of monoclonal antibodies for inhalation to eliminate deadline failures, with the current metric standing at -0.02. This price action chart helps track this sector. The business is based on developing nasal agents to combat neuroinflammation in Alzheimer's and sclerosis, integrating comfortable immunotherapy methods into the overall therapeutic environment.
Summary analytical data breakdowns for tizianalifesciences.com (TLSA)
- current quotes and average value forecast:
- stock exchange capitalization data:
- business book valuation details:
- debt level and financial liquidity data:
Total Debt to Capital Tiziana Life Sciences|TLSA - Long-Term Debt to Capital|Short-Term Debt to Equity Tiziana Life Sciences Ltd|TLSA - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Tiziana Life Sciences Ltd|TLSA - Company Long-Term Liabilities|Company Short-Term Debts Tiziana Life Sciences|Quick Liquidity Indicator tizianalifesciences.com
- earnings and multiples data:
General company analysis:TLSA - Tiziana Life Sciences PLC
For Tiziana Life Sciences (TLSA), which is developing innovative nasal immunotherapy for multiple sclerosis, this indicator reflects the actual net asset value per share. By analyzing the history of book value per share, an investor assesses the company's residual equity minus liabilities, allowing for a comparison of the company's fundamental base against the clinical trial costs of foralumab.
Competitor analysis
ARGX - Net Assets per Single Share|Net Assets per Share BioNTech Pharma BNTX|ABVX: Book Value per Share|admabiologics.com (ADMA) - Book Value per Share|Net Assets per Single Share Protagonist|Immunovant Inc - Share Book Value|Book Value per Share KNSA|GRFS (Grifols Biemat) - Accounting Value of a Share|Book Value per Share ADPT (Adaptive Biotechnologies)|Book Value per Share celldex.com CLDX|AUPH - Net Assets per Single Share|Accounting Value of a Share BCRX (BioCryst Pharmaceuticals, Inc.)|Vera Pharma (VERA) - Net Assets per Single Share|Accounting Value per Share Dianthus Corp|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp|Accounting Value per Share TRML (Tourmaline Bio)|PGEN (Precigen Inc) - Accounting Value of a Share|Book Value per Share PHAR (Pharming)|Net Assets per Share Nektar Corp (NKTR)|UPB - Net Assets per Single Share|zenasbio.com (ZBIO) - Accounting Value per Share|Immunome (IMNM) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|Accounting Value per Share KALV|Book Value per Share Septerna Pharma|Net Assets per Single Share Pieris Pharmaceuticals (PVLA)|savarapharma.com - Equity per Share|Book Value per Share RIGL (Rigel Pharmaceuticals, Inc.)|AnaptysBio Inc (ANAB) - Net Asset Value per Share|ATXS: Accounting Value per Share|enGene Corp - Book Price of a Share|RAPT: Book Value per Share|JBIO - Net Assets per Share|Accounting Value per Share ACRS|Kyverna Therapeutics Inc. - Share Book Value|Book Value per Share CABA|Net Assets per Share Ventyx Biosciences, Inc|Book Value per Share THTX (Theratechnologies Inc.)|Book Value per Share avalotx.com AVTX|ELDN - Net Assets per Single Share|AGEN (Agenus, Inc.) - Equity per Share|CLYM: Book Value per Share|Zura Bio Ltd (ZURA) - Book Value per Share|Accounting Value per Share ATYR|ADAG: Accounting Value of a Share|Net Assets per Single Share ImageneBio Inc (IMA)|Net Assets per Single Share STTK (shattucklabs.com)|Book Value per Share EQ (Equillium)|Net Assets per Share Connect Biopharma Holdings (CNTB)|Immunic Inc - Book Value per Share|Share Book Value ATRA|IFRX: Book Value per Share|Net Asset Value per Share X4 Pharmaceuticals Inc. (XFOR)|Accounting Value per Share ACET|CELU: Accounting Value of a Share|Net Assets per Single Share INmune Bio, Inc. (INMB)|Net Assets per Share barinthusbio.com|Book Value per Share KZR (Kezar Life Sciences, Inc.)|SABS - Accounting Value per Share|Akari Therapeutics plc - Book Value per Share|Net Assets per Share Enlivex Therapeutics ENLV|QTTB: Book Value per Share|Net Asset Value per Share geovax.com (GOVX)|Net Assets per Single Share Edesa Biotech|Equity per Share IBIO (iBio Inc)|Book Value per Share CARM|Accounting Value per Share XTL Bio XTLB|Book Value per Share BOLT (Bolt Biotherapeutics, Inc.)|HCW Biologics, Inc. (HCWB) - Net Asset Value per Share|APVO - Net Assets per Single Share|Net Assets per Share AIM ImmunoTech, Inc. AIM|ADTX (aditxt.com) - Accounting Value per Share|GRI: Book Price of a Share|Net Assets per Single Share XORTX Therapeutics Inc.|Net Assets per Single Share HIND|Net Assets per Single Share Revelation Biosciences, Inc. (REVB)|Net Assets per Share Indaptus Therapeutics Inc|Book Value per Share SCNI (Scinai)|Book Value per Share CalciMedica Inc CALI|AFMD - Net Assets per Single Share|Share Book Value ALLK|HOOK: Book Value per Share|IGM Biosciences - Accounting Value of a Share|ITOS (iTeos) - Book Value per Share|Book Value per Share Ocean Biomedical Corp|Net Assets per Single Share TC Biopharm (TCBP)|THRD (thirdharmonicbio.com) - Accounting Value of a Share